AMPH
Amphastar PNASDAQHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$905.23M
P/E Ratio
12.37
EPS
$1.66
Beta
0.90
52W High
$31.26
52W Low
$16.64
50-Day MA
$20.20
200-Day MA
$24.30
Dividend Yield
—
Profit Margin
11.00%
Forward P/E
—
PEG Ratio
2.77
About Amphastar P
Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company is headquartered in Rancho Cucamonga, California.
Fundamentals
| Revenue (TTM) | $720.53M |
| Gross Profit (TTM) | $341.13M |
| EBITDA | $197.27M |
| Operating Margin | 7.96% |
| Return on Equity | 10.40% |
| Return on Assets | 5.34% |
| Revenue/Share (TTM) | $15.61 |
| Book Value | $17.33 |
| Price-to-Book | 1.17 |
| Price-to-Sales (TTM) | 1.26 |
| EV/Revenue | 1.804 |
| EV/EBITDA | 6.73 |
| Quarterly Earnings Growth (YoY) | -72.50% |
| Quarterly Revenue Growth (YoY) | 0.40% |
| Shares Outstanding | $44.09M |
| Float | $32.82M |
| % Insiders | 29.74% |
| % Institutions | 76.38% |
Historical Volatility
HV 10-Day
43.84%
HV 20-Day
36.76%
HV 30-Day
82.34%
HV 60-Day
63.66%
HV Rank
83.7%
Volatility is currently contracting
Analyst Ratings
Consensus ($22.83 target)
7
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026